Revision history of "Study of gliomas: large-scale sequencing analysis, molecular techniques, imaging techniques and clinical data analysis. Generation of a diagnostic platform." (Q3209282)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 March 2024

21 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 12:0512:05, 18 August 2022DG Regio talk contribs 82,647 bytes +57,073 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

5 December 2021

14 October 2021

  • curprev 09:3009:30, 14 October 2021DG Regio talk contribs 13,341 bytes +216 Changed label, description and/or aliases in en: translated_label
  • curprev 09:3009:30, 14 October 2021DG Regio talk contribs 13,125 bytes +2,587 Created claim: summary (P836): Gliomas constitute a clinically heterogeneous tumor entity, encompassing various histological subtypes and degrees. Although they are not yet included in the WHO diagnostic criteria, specific molecular alterations have been identified in some glioma subtypes, such as 1p/19q co-deletion in oligodendroglial tumors associated with better prognosis and response to treatment. Another marker of good prognosis is mutation in IDH genes, an early event i...

11 October 2021

10 October 2021

9 October 2021